200-kW Gas-fired Microturbines to power CHP and Cooling plant at planned T-Cell Therapy Manufacturing site
A manufacturer of T-cell therapies for the health care industry has ordered gas-fired microturbines for the combined cooling heat and power (CCHP) system at its planned facility in Maryland.
Massachusetts-based TCR2 Therapeutics is planning to create an 85,000-square-foot cell therapy manufacturing facility in Rockville. The new CCHP system would feature Capstone Green Energy’s 200-kW C1000S gas-fueled microturbines.
The overall 1-MW system also would include Capstone’s integrated heat recovery modules and an E-Finity m-Tim controller with remote monitoring.
On Demand: See our Webcast featuring how Penn St. Health System updated Energy System
Despite Federal Impediments, HealthCare Systems pursue Decarbonization
The monitoring system will oversee and control a 300-ton absorption chiller and all five heat recovery modules to help ensure peak performance. The system offers immediate backup power in the event of a utility outage.
The facility is expected to be commissioned in January 2023.
Subscribe to EnergyTech's free, tri-weekly Newsletter as we cover the Mission Critical Energy sector
"Reliability is critical for this project," said Tom McGeehan, Vice President of Sales for E-Finity. "Any disruption to power can cost lives. Having the redundancy of the five 200 kW modular turbines that can operate independently of each other and in parallel are key. It is important that if one turbine is shut down for maintenance, the other four will continue to provide power."
TCR2 is a clinical-stage cell therapy manufacturer. The technology seeks to boost natural T-cell immunity responses to fight tumors. T cells are white blood cells within the immunity response system.
-- -- --
(Rod Walton, senior editor for EnergyTech, is a 14-year veteran of covering the energy industry both as a newspaper and trade journalist. He can reached at [email protected]).